The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA)

Atherosclerosis

Volumn 258, Issue , 2017, Pages 119-130

  Al Rifai, Mahmoud ^a,b   DeFillippis, Andrew P ^b,c   McEvoy, John W ^b   Hall, Michael E ^d   Acien, Ana Navas ^e   Jones, Miranda R ^e   Keith, Rachel ^c   Magid, Hoda S ^f   Rodriguez, Carlos J ^g   Barr, Graham R ^h   Benjamin, Emelia J ⁱ   Robertson, Rose Marie ^j   Bhatnagar, Aruni ^c   Blaha, Michael J ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h Department of Medicine   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j AMERICAN HEART ASSOCIATION   (United States)

more..

Author keywords

Cigarette smoking; Endothelial damage; Inflammation; Myocardial injury; Smoking intensity; Thrombosis; Tobacco regulatory science; Vascular dysfunction

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COTININE; CREATININE; D DIMER; FIBRINOGEN; HIGH SENSITIVITY C REACTIVE PROTEIN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 2; INTERLEUKIN 6; TROPONIN T; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AFRICAN AMERICAN; AORTA; ARTICLE; ASIAN AMERICAN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM INJURY; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; FLOW-MEDIATED DILATION TEST; HEART MUSCLE INJURY; HISPANIC; HUMAN; HYPERTENSION; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SMOKING; THROMBOSIS; AGED; ARTERIAL STIFFNESS; BLOOD; BLOOD CLOTTING; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; EPIDEMIOLOGY; ETHNOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; STATISTICAL MODEL; UNITED STATES; URINE; VASODILATATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD COAGULATION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COTININE; CROSS-SECTIONAL STUDIES; CYTOKINES; EARLY DIAGNOSIS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HOMOCYSTEINE; HUMANS; INFLAMMATION MEDIATORS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SMOKING; TROPONIN T; UNITED STATES; VASCULAR STIFFNESS; VASODILATION;

EID: 85013647958     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.01.021     Document Type: Article

References (64)

1. [1] WHO, WHO Report on the Global Tobacco Epidemic., 2011 http://www.who.int/tobacco/global_report/2011/en/ (Accessed 14.11.15).
2. [2] The Health consequences of Smoking—50 Years of progress: a report of the surgeon general. http://www-ncbi-nlm-nih-gov.ezproxy.welch.jhmi.edu/pubmed/?term%0d.The+Health+Consequences+of+Smoking%25E2%2580%259450+Years+of+Progress%253A+A+Report+of+the+Surgeon+General (Accessed 07.06.14).
3. [3] Ezzati, M., Henley, S.J., Thun, M.J., Lopez, A.D., Role of smoking in global and regional cardiovascular mortality. Circulation 112:4 (2005), 489–497, 10.1161/CIRCULATIONAHA.104.521708.
4. [4] McEvoy, J.W., Nasir, K., DeFilippis, A.P., et al. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., March 2015, 10.1161/ATVBAHA.114.304960.
5. [5] McEvoy, J.W., Blaha, M.J., DeFilippis, A.P., et al. Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., January 2015, 10.1161/ATVBAHA.114.304562.
6. [6] Pell, J.P., Haw, S., Cobbe, S., et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N. Engl. J. Med. 359:5 (2008), 482–491, 10.1056/NEJMsa0706740.
7. [7] Rosenberg, L., Kaufman, D.W., Helmrich, S.P., Shapiro, S., The risk of myocardial infarction after quitting smoking in men under 55 years of age. N. Engl. J. Med. 313:24 (1985), 1511–1514, 10.1056/NEJM198512123132404.
8. [8] Dobson, A.J., Alexander, H.M., Heller, R.F., Lloyd, D.M., How soon after quitting smoking does risk of heart attack decline?. J. Clin. Epidemiol. 44:11 (1991), 1247–1253, 10.1016/0895-4356(91)90157-5.
9. [9] Nance, R., Delaney, J., McEvoy, J.W., et al. Smoking intensity [pack/day] is a better measure than pack-years or smoking status for modeling cardiovascular disease outcomes. J. Clin. Epidemiol., October 2016, 10.1016/j.jclinepi.2016.09.010.
10. [10] Koczulla, A.-R., Noeske, S., Herr, C., et al. Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers. Respiration 79:1 (2010), 61–67, 10.1159/000245325.
11. [11] van der Vaart, H., Postma, D.S., Timens, W., et al. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir. Res., 6, 2005, 22, 10.1186/1465-9921-6-22.
12. [12] Ciftci, O., Caliskan, M., Gullu, H., et al. Acute effects of smoking light cigarettes on coronary microvascular functions. Clin. Cardiol. 32:4 (2009), 210–214, 10.1002/clc.20343.
13. [13] Otsuka, R., Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA, 286(4), 2001, 436, 10.1001/jama.286.4.436.
14. [14] Kubozono, T., Miyata, M., Ueyama, K., et al. Acute and chronic effects of smoking on arterial stiffness. Circ. J 75:3 (2011), 698–702 http://www.ncbi.nlm.nih.gov/pubmed/21187657 (Accessed October 28.10.15).
15. [15] LEVINE, P.H., An acute effect of cigarette smoking on platelet function: a possible link between smoking and arterial thrombosis. Circulation 48:3 (1973), 619–623, 10.1161/01.CIR.48.3.619.
16. [16] Taha, N.M., Abdel Wahab, M.A., Amin, A.S., Acute effects of cigarette smoking in habitual smokers, a focus on endothelial function. Egypt Hear J. 65:4 (2013), 275–279, 10.1016/j.ehj.2012.09.003.
17. [17] K. Sassalos, C. Vlachopoulos, N. Alexopoulos, T. Gialernios, K. Aznaouridis, C. Stefanadis, The acute and chronic effect of cigarette smoking on the elastic properties of the ascending aorta in healthy male subjects, Hell. J. Cardiol. 47(5) 263–268. http://www.ncbi.nlm.nih.gov/pubmed/17134061. (Accessed 29.10.15).
18. [18] Levitzky, Y.S., Guo, C.-Y., Rong, J., et al. Relation of smoking status to a panel of inflammatory markers: the Framingham offspring. Atherosclerosis 201:1 (2008), 217–224, 10.1016/j.atherosclerosis.2007.12.058.
19. [19] Avila-Tang, E., Al-Delaimy, W.K., Ashley, D.L., et al. Assessing secondhand smoke using biological markers. Tob. Control 22:3 (2013), 164–171, 10.1136/tobaccocontrol-2011-050298.
20. [20] Jones, M.R., Magid, H.S., Al-Rifai, M., et al. Secondhand smoke exposure and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis. J. Am. Heart Assoc., 5(12), 2016, e002965, 10.1161/JAHA.115.002965.
21. [21] Bild, D.E., Bluemke, D.A., Burke, G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am. J. Epidemiol. 156:9 (2002), 871–881 http://www.ncbi.nlm.nih.gov/pubmed/12397006 (Accessed 19.08.14).
22. [22] Donohue, K.M., Hoffman, E.A., Baumhauer, H., et al. Asthma and lung structure on computed tomography: the multi-ethnic study of atherosclerosis Lung study. J. Allergy Clin. Immunol., 131(2), 2013, 10.1016/j.jaci.2012.11.036 361–8-11.
23. [23] McDonald, S.P., Maguire, G.P., Hoy, W.E., Validation of self-reported cigarette smoking in a remote Australian aboriginal community. Aust. N. Z. J. Public Health 27:1 (2003), 57–60, 10.1111/j.1467-842X.2003.tb00380.x.
24. [24] Etter, J.F., Perneger, T.V., Measurement of self reported active exposure to cigarette smoke. J. Epidemiol. Community Health 55:9 (2001), 674–680 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid%0d1731967%26tool%0dpmcentrez%26rendertype%0dabstract (Accessed 29.12.15).
25. [25] Bakhru, A., Erlinger, T.P., Smoking cessation and cardiovascular disease risk factors: results from the third national health and nutrition examination survey. PLoS Med., 2(6), 2005, e160, 10.1371/journal.pmed.0020160.
26. [26] Blaha, M.J., Budoff, M.J., DeFilippis, A.P., et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 378:9792 (2011), 684–692, 10.1016/S0140-6736(11)60784-8.
27. [27] Damluji, A.A., Ramireddy, A., Al-Damluji, M.S., et al. Association between anti-human heat shock protein-60 and interleukin-2 with coronary artery calcium score. Heart 101:6 (2015), 436–441, 10.1136/heartjnl-2014-306649.
28. [28] Caruso, C., Candore, G., Cigna, D., Colucci, A.T., Modica, M.A., Biological significance of soluble IL-2 receptor. Mediat. Inflamm. 2:1 (1993), 3–21, 10.1155/S0962935193000018.
29. [29] Kawut, S.M., Barr, R.G., Johnson, W.C., et al. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV study. Biomarkers 15:8 (2010), 731–738, 10.3109/1354750X.2010.516455.
30. [30] Ferrari, R., Bachetti, T., Confortini, R., et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92:6 (1995), 1479–1486 http://www.ncbi.nlm.nih.gov/pubmed/7664430 (Accessed 09.12.15.
31. [31] Harhay, M.O., Tracy, R.P., Bagiella, E., et al. Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-right ventricle study. Int. J. Cardiol. 168:4 (2013), 3818–3824, 10.1016/j.ijcard.2013.06.028.
32. [32] Neuhaus, J., Jacobs, D.R., Baker, J.V., et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J. Infect. Dis. 201:12 (2010), 1788–1795, 10.1086/652749.
33. [33] Perng, W., Villamor, E., Shroff, M.R., et al. Dietary intake, plasma homocysteine, and repetitive element DNA methylation in the Multi-Ethnic Study of Atherosclerosis (MESA). Nutr. Metab. Cardiovasc Dis. 24:6 (2014), 614–622, 10.1016/j.numecd.2013.11.011.
34. [34] Zemaitis, P., Liu, K., Jacobs, D.R., et al. Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis. Clin. J. Am. Soc. Nephrol. 9:11 (2014), 1922–1929, 10.2215/CJN.02450314.
35. [35] Redheuil, A., Wu, C.O., Kachenoura, N., et al. Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: the MESA study. J. Am. Coll. Cardiol. 64:24 (2014), 2619–2629, 10.1016/j.jacc.2014.09.060.
36. [36] Blaha, M.J., Budoff, M.J., Rivera, J.J., et al. Relationship of carotid distensibility and thoracic aorta calcification: multi-ethnic study of atherosclerosis. Hypertension 54:6 (2009), 1408–1415, 10.1161/HYPERTENSIONAHA.109.138396.
37. [37] Gamble, G., Zorn, J., Sanders, G., MacMahon, S., Sharpe, N., Estimation of arterial stiffness, compliance, and distensibility from M-mode ultrasound measurements of the common carotid artery. Stroke 25:1 (1994), 11–16 http://www.ncbi.nlm.nih.gov/pubmed/8266356 (Accessed 19.02.16).
38. [38] Yeboah, J., Folsom, A.R., Burke, G.L., et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120:6 (2009), 502–509, 10.1161/CIRCULATIONAHA.109.864801.
39. [39] Daniels, L.B., Clopton, P., deFilippi, C.R., et al. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA). Am. Heart J., September 2015, 10.1016/j.ahj.2015.09.010.
40. [40] Bapat, A., Zhang, Y., Post, W.S., et al. Relation of physical activity and incident atrial fibrillation (from the multi-ethnic study of atherosclerosis). Am. J. Cardiol. 116:6 (2015), 883–888, 10.1016/j.amjcard.2015.06.013.
41. [41] J. Cuzick, A Wilcoxon-type test for trend, Stat. Med. 4(1) 87–90. http://www.ncbi.nlm.nih.gov/pubmed/3992076. (Accessed 06.11.15).
42. [42] Benowitz, N.L., Hukkanen, J., Jacob, P., Nicotine chemistry, metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 192 (2009), 29–60, 10.1007/978-3-540-69248-5_2.
43. [43] Pope, C.A., Burnett, R.T., Krewski, D., et al. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation 120:11 (2009), 941–948, 10.1161/CIRCULATIONAHA.109.857888.
44. [44] Schane, R.E., Ling, P.M., Glantz, S.A., Health effects of light and intermittent smoking: a review. Circulation 121:13 (2010), 1518–1522, 10.1161/CIRCULATIONAHA.109.904235.
45. [45] Kaptoge, S., Di Angelantonio, E., Pennells, L., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N. Engl. J. Med. 367:14 (2012), 1310–1320, 10.1056/NEJMoa1107477.
46. [46] Gonçalves, R.B., Coletta, R.D., Silvério, K.G., et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm. Res. 60:5 (2011), 409–424, 10.1007/s00011-011-0308-7.
47. [47] Petrescu, F., Voican, S.C., Silosi, I., Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. Int. J. Chron. Obstr. Pulm. Dis. 5 (2010), 217–222 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid%0d2921689%26tool%0dpmcentrez%26rendertype%0dabstract (Accessed 24.02.16).
48. [48] Barbieri, S.S., Zacchi, E., Amadio, P., et al. Cytokines present in smokers’ serum interact with smoke components to enhance endothelial dysfunction. Cardiovasc Res. 90:3 (2011), 475–483, 10.1093/cvr/cvr032.
49. [49] Drost, E.M., Selby, C., Bridgeman, M.M., MacNee, W., Decreased leukocyte deformability after acute cigarette smoking in humans. Am. Rev. Respir. Dis. 148:5 (1993), 1277–1283, 10.1164/ajrccm/148.5.1277.
50. [50] Patiar, S., Slade, D., Kirkpatrick, U., McCollum, C.N., Smoking causes a dose-dependent increase in granulocyte-bound L-selectin. Thromb. Res. 106:1 (2002), 1–6 http://www.ncbi.nlm.nih.gov/pubmed/12165281 (Accessed 28.10.15).
51. [51] Caponnetto, P., Russo, C., Di Maria, A., et al. Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study. Eur. J. Clin. Invest 41:6 (2011), 616–626, 10.1111/j.1365-2362.2010.02449.x.
52. [52] Nowak, J., Murray, J.J., Oates, J.A., FitzGerald, G.A., Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 76:1 (1987), 6–14 http://www.ncbi.nlm.nih.gov/pubmed/3297389 (Accessed 24.02.16).
53. [53] Sambola, A., Osende, J., Hathcock, J., et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107:7 (2003), 973–977 http://www.ncbi.nlm.nih.gov/pubmed/12600909 (Accessed 24.02.16.
54. [54] Lupia, E., Bosco, O., Goffi, A., et al. Thrombopoietin contributes to enhanced platelet activation in cigarette smokers. Atherosclerosis 210:1 (2010), 314–319, 10.1016/j.atherosclerosis.2009.11.019.
55. [55] Chen, S., Wu, P., Zhou, L., Shen, Y., Li, Y., Song, H., Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease. Int. J. Clin. Exp. Med. 8:3 (2015), 4446–4454 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid%0d4443202%26tool%0dpmcentrez%26rendertype%0dabstract (Accessed 09.12.15.
56. [56] Takac, I., Schröder, K., Brandes, R.P., The Nox family of NADPH oxidases: friend or foe of the vascular system?. Curr. Hypertens. Rep. 14:1 (2012), 70–78, 10.1007/s11906-011-0238-3.
57. [57] Poredos, P., Orehek, M., Tratnik, E., Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology 50:3 (1999), 201–208 http://www.ncbi.nlm.nih.gov/pubmed/10088799 (Accessed 29.10.15).
58. [58] Skaug, E.-A., Aspenes, S.T., Oldervoll, L., et al. Age and gender differences of endothelial function in 4739 healthy adults: the HUNT3 fitness study. Eur. J. Prev. Cardiol. 20:4 (2013), 531–540, 10.1177/2047487312444234.
59. [59] Doonan, R.J., Hausvater, A., Scallan, C., Mikhailidis, D.P., Pilote, L., Daskalopoulou, S.S., The effect of smoking on arterial stiffness. Hypertens. Res. 33:5 (2010), 398–410, 10.1038/hr.2010.25.
60. [60] Miyazaki, T., Ashikaga, T., Ohigashi, H., Komura, M., Kobayashi, K., Isobe, M., Impact of smoking on coronary microcirculatory resistance in patients with coronary artery disease. Int. Heart J. 56:1 (2015), 29–36, 10.1536/ihj.14-189.
61. [61] Al-Otaiby, M.A., Al-Amri, H.S., Al-Moghairi, A.M., The clinical significance of cardiac troponins in medical practice. J. Saudi Hear Assoc. 23:1 (2011), 3–11, 10.1016/j.jsha.2010.10.001.
62. [62] Ridker, P.M., Rifai, N., Stampfer, M.J., Hennekens, C.H., Plasma concentration of Interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:15 (2000), 1767–1772, 10.1161/01.CIR.101.15.1767.
63. [63] Guttormsen, A.B., Mansoor, A.M., Fiskerstrand, T., Ueland, P.M., Refsum, H., Kinetics of plasma homocysteine in healthy subjects after peroral homocysteine loading. Clin. Chem. 39:7 (1993), 1390–1397 http://www.ncbi.nlm.nih.gov/pubmed/8330395 (Accessed 24.02.16).
64. [64] White, H.D., Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?. J. Am. Coll. Cardiol. 57:24 (2011), 2406–2408, 10.1016/j.jacc.2011.01.029.